On-Demand Webcast


Program Content


  • HER2-Positive Advanced GI Cancers
    HER2-Positive Advanced Gastrointestinal Cancers: Expert Guidance on Leveraging Targeted Agents to Improve Outcomes
    Congratulations: You achieved a completion on 04/09/2022

    Released: June 21, 2023

    Expires: June 20, 2024

    View Activity


cover img faculity

Geoffrey Ku, MD

Associate Attending Physician
Head, Esophagogastric Section, Gastrointestinal Oncology Service & member, Cellular Therapy Service
Department of Medicine

cover img faculity

Kanwal Raghav, MD

Associate Professor
Gastrointestinal Medical Oncology
The University of Texas MD Anderson Cancer Center
Houston, Texas

cover img faculity

Zev A. Wainberg, MD

Professor of Medicine and Surgery
Department of Hematology
Division of Oncology
University of California School of Medicine
Los Angeles, California

Provided by

ProCE Banner


Supported by educational grants from AstraZeneca, Daiichi Sankyo, Inc., and Seagen Inc.


Daiichi Sankyo, Inc.

Seagen Inc.